Recent research indicates that pharmacological agents may enhance psychotherapeutic outcome. Yet empirical results have not been conclusive with respect to two pharmacological agents yohimbine hydrochloride YOH and propranolol. YOH is suggested to enhance emotional memory by elevating norepinephrine whereas the -adrenergic receptor antagonist propranolol might help better cope with feared situations by reducing accompanying bodily sensations. Enhancement of exposure therapy in participants with specific phobia: A randomized controlled trial comparing yohimbine propranolol and placebo.